Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab ; volume:12 ; number:5 ; day:13 ; month:6 ; year:2023 ; pages:2397-2408 ; date:10.2023
Ophthalmology and therapy ; 12, Heft 5 (13.6.2023), 2397-2408, 10.2023
- Urheber
-
Zubricky, Ryan
McCoy, Jasmyne
Donkor, Richard
Miller, David G.
Sonbolian, Nina
Heaney, Andrew
Bilano, Ver
Karcher, Helene
Coney, Joseph M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-023-00741-w
- URN
-
urn:nbn:de:101:1-2023110607543601882789
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zubricky, Ryan
- McCoy, Jasmyne
- Donkor, Richard
- Miller, David G.
- Sonbolian, Nina
- Heaney, Andrew
- Bilano, Ver
- Karcher, Helene
- Coney, Joseph M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Efficacy and Durability of Faricimab in Naïve Eyes with Neovascular Age-Related Macular Degeneration
Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen
Ocular Characteristics of Pseudophakic Eyes with Malignant Glaucoma
Chorioretinal thickness and retinal pigment epithelial degeneration of fellow eyes in patients with unilateral neovascular age-related macular degeneration with subretinal drusenoid deposits
Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR)
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Photodynamic therapy of choroidal neovascular membranes associated with exudative age-related macular degeneration
Prechoroidal cleft thickness correlates with disease activity in neovascular age-related macular degeneration
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Efficacy and Durability of Faricimab in Naïve Eyes with Neovascular Age-Related Macular Degeneration
Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen
Ocular Characteristics of Pseudophakic Eyes with Malignant Glaucoma
Chorioretinal thickness and retinal pigment epithelial degeneration of fellow eyes in patients with unilateral neovascular age-related macular degeneration with subretinal drusenoid deposits
Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR)
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Photodynamic therapy of choroidal neovascular membranes associated with exudative age-related macular degeneration
Prechoroidal cleft thickness correlates with disease activity in neovascular age-related macular degeneration
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Efficacy and Durability of Faricimab in Naïve Eyes with Neovascular Age-Related Macular Degeneration
Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen
Ocular Characteristics of Pseudophakic Eyes with Malignant Glaucoma
Chorioretinal thickness and retinal pigment epithelial degeneration of fellow eyes in patients with unilateral neovascular age-related macular degeneration with subretinal drusenoid deposits
Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR)
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Photodynamic therapy of choroidal neovascular membranes associated with exudative age-related macular degeneration
Prechoroidal cleft thickness correlates with disease activity in neovascular age-related macular degeneration